GVD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GVD, covering 2022-05-09 to 2022-05-09. Get the full timeline:
Most recent: Clinical Trial Update: PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL [Phase 2]